News & Events

On December 18, 2017, Lynn L. Bergeson, Managing Partner of Bergeson & Campbell, P.C. (B&C®), was quoted by the Bloomberg BNA Daily Environment Report in the article “FDA Pushes Risk-Based Approach to Nanomaterial Drugs.” Developers of drugs containing nanomaterials—substances so small they can't be seen with a regular microscope—got some advice on how to assess their risks in FDA draft guidance issued Dec. 15. […] Without having read it in detail yet, Lynn...

On December 15, 2017, Chemical Watch featured comments by the TSCA New Chemicals Coalition (NCC) on the U.S. Environmental Protection Agency’s (EPA) new chemical evaluation policy. An industry group has argued that the US EPA should avoid issuing orders to mitigate workplace risks associated with new chemicals. Instead, it says, it should turn over that regulatory responsibility to the Occupational Health and Safety Administration (Osha). The TSCA New Chemicals Coalition...

On December 11, 2017, Richard E. Engler, Ph.D., Senior Chemist at Bergeson & Campbell, P.C. (B&C®), was quoted in Chemical Watch regarding concerns with the U.S. Environmental Protection Agency’s (EPA) plan to move away from consent orders in favor of Significant New Use Rules (SNURs) when regulating potential uses of new chemicals. When the situation described in a pre-manufacture notice (PMN) is not of concern, but there is a potential use of the new chemical that...

On December 11, 2017, Lynn L. Bergeson, Managing Partner of Bergeson & Campbell, P.C. (B&C®), was quoted in the Chemical Week article “Trump's EPA: TSCA remains priority amid regulatory rollback.” “Not surprisingly, there’s been a tremendous focus on the implementation requirements for Lautenberg,” says Lynn Bergeson, managing partner of Bergeson & Campbell (Washington, DC). Efforts have included building a conceptual framework of how to review and apply the...

The Acta Group (Acta®) and Bergeson & Campbell, P.C. (B&C®) are pleased to announce that Scott J. Burya, Ph.D. has joined our firms as a Regulatory Chemist.  Dr. Burya holds a Ph.D. in analytical chemistry from the Ohio State University and will support clients in all stages of product development, from assessing the toxicology and regulatory profiles of new substances, performing quantitative risk assessments, and navigating state and federal regulations, to guiding teams through...

On November 29, 2017, Lynn L. Bergeson, Managing Partner of Bergeson & Campbell, P.C. (B&C®), and Richard E. Engler, Ph.D., Senior Chemist at B&C, were quoted by Bloomberg BNA Daily Environment Report regarding recently released U.S. Environmental Protection Agency (EPA) documents on new chemical review procedures. The Points to Consider When Preparing TSCA New Chemical Notifications document, in particular, provides a clear, useful summary of the agency's...

Bergeson & Campbell, P.C. (B&C®) is pleased to inform our clients and friends of the publication by Bloomberg BNA of EHS Strategies:  The Evolving Landscape of TSCA Reform Implementation, the latest edition of BNA’s quarterly EHS Strategies report.  The report provides a comprehensive analysis of recent Toxic Substances Control Act (TSCA) developments written by many of the key players in the development, passage, and implementation of the Frank R. Lautenberg Chemical...

On October 25, 2017, Brian Xu, M.D., PH.D., DABT®, toxicologist with Bergeson & Campbell, P.C. (B&C®), was quoted by Bloomberg BNA Daily Environment Report regarding China’s updated pesticide regulations. China's pesticide regulations were updated in the Agriculture Ministry's Order No. 3, which went into effect Aug. 1, but observers said disparities still exist between that directive and the subsequent Proclamation No. 2569, which details the data companies...

On October 12, 2017, Lynn L. Bergeson, Managing Partner, Bergeson & Campbell, P.C. (B&C®), presented at the “Innovative Consumer Products and Legal Risk” breakout session at the 2017 Retail Law Conference in Chicago, Illinois. The Retail Industry Leaders Association’s (RILA) Retail Litigation Center hosts this annual gathering of in-house counsel to cover pressing issues facing the retail industry and provide opportunity for interactive participation in roundtable...

On October 6, 2017, Inside EPA quoted a recent Bergeson & Campbell, P.C. (B&C®) memorandum in the article “EPA wins power to oversee biotech mosquito controls.” EPA and the Food and Drug Administration (FDA) have issued new guidance clarifying that EPA has authority for regulating biotechnology (Bt) products such as genetically modified mosquitoes that are used to control the pests, a step that one industry law firm says will be helpful for navigating a federal...